Screener
Monte Rosa Therapeutics, Inc. GLUE Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
| (in thousands, except share and per share amounts) | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 5,382 | 4,481 |
| Total current assets | 631,406 | 393,185 |
| Property and equipment, net | 29,932 | 25,986 |
| Operating lease right-of-use assets | 24,056 | 24,386 |
| Restricted cash | 4,939 | 4,954 |
| Other long-term assets | 828 | 148 |
| Total assets | $691,161 | $448,659 |
| Liabilities and stockholders’ equity |
Item 1. Financial Statements
FAQ
- What is Monte Rosa Therapeutics, Inc.'s operating lease ROU assets?
- Monte Rosa Therapeutics, Inc. (GLUE) reported operating lease ROU assets of $24.06M in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s operating lease ROU assets decreased by 6.3% year-over-year, from $25.67M to $24.06M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Monte Rosa Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude